Migraine study: EVO756
Official title Study of EVO756 in Adults With Migraine
ClinicalTrials.gov ID: NCT07616128
What this study is testing
What is EVO756?
an investigational oral medicine being studied as a potential treatment for migraine
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether EVO756 helps reduce migraine pain and how safe it is compared to a pretend treatment.
- Who it's for
- You may be able to join if you are an adult who gets migraines and can follow the study rules.
- What's involved
- You will take the medicine or a pretend treatment and share how you feel. You may have a few check‑in visits.
- Time commitment
- The study lasts a few weeks and includes a few visits to the clinic.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- Adults aged 18 to \<65 years
- Migraine with or without aura, per ICHD-3 criteria
- History of failure with prior preventive migraine treatments
- Not currently using migraine preventive therapy Key
You likely can't join if
- Difficulty distinguishing migraine from other headache types or presence of other primary headache disorders
- Use of certain medications
- Any clinically significant medical, psychiatric, neurological, cardiovascular, or laboratory abnormalities
The study team makes the final eligibility decision.
Where it is enrolling
- Chandler, Arizona, United States
- Fresno, California, United States
- La Jolla, California, United States
- Los Angeles, California, United States
- Walnut Creek, California, United States
- Denver, Colorado, United States
- New Haven, Connecticut, United States
- Stamford, Connecticut, United States
- Miami, Florida, United States
- Orlando, Florida, United States
- Tampa, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
- Decatur, Georgia, United States
- Foxborough, Massachusetts, United States
- Westborough, Massachusetts, United States
- Ann Arbor, Michigan, United States
- Farmington Hills, Michigan, United States
- Papillion, Nebraska, United States
- Toms River, New Jersey, United States
+ 20 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chandler, Arizona, United States; Fresno, California, United States; La Jolla, California, United States; Los Angeles, California, United States; Walnut Creek, California, United States; Denver, Colorado, United States and 34 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.